201 related articles for article (PubMed ID: 36499093)
1. Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma.
Vlachová M; Gregorová J; Vychytilová-Faltejsková P; Gabło NA; Radová L; Pospíšilová L; Almáši M; Štork M; Knechtová Z; Minařík J; Popková T; Jelínek T; Hájek R; Pour L; Říhová L; Ševčíková S
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499093
[TBL] [Abstract][Full Text] [Related]
2. [MicroRNA Analysis for Extramedullary Multiple Myeloma Relapse].
Gregorová J; Vrábel D; Radová L; Gablo NA; Almaši M; Štork M; Slabý O; Pour L; Minařík J; Ševčíková S
Klin Onkol; 2018; 31(Supplementum1):148-150. PubMed ID: 29808690
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of the bone marrow microenvironment in extramedullary multiple myeloma patients.
Gregorova J; Vychytilova-Faltejskova P; Kramarova T; Knechtova Z; Almasi M; Stork M; Pour L; Kohoutek J; Sevcikova S
Neoplasma; 2022 Mar; 69(2):412-424. PubMed ID: 35037760
[TBL] [Abstract][Full Text] [Related]
4. Genetic Abnormalities in Extramedullary Multiple Myeloma.
McAvera R; Quinn J; Murphy P; Glavey S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511018
[TBL] [Abstract][Full Text] [Related]
5. Altered Expression of MicroRNAs in the Bone Marrow of Multiple Myeloma Patients and their Relationship to Cytogenetic Aberrations.
Attia HRM; Abdelrahman AH; Ibrahim MH; Eid MM; Eid OM; Sallam MT; El Gammal MM; Kamel MM
Curr Pharm Biotechnol; 2020; 21(13):1394-1401. PubMed ID: 32196445
[TBL] [Abstract][Full Text] [Related]
6. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival.
Roseth Aass K; Nedal TMV; Anshushaug Bouma S; Tryggestad SS; Haukås E; Slørdahl TS; Waage A; Standal T; Mjelle R
Br J Cancer; 2023 Feb; 128(4):656-664. PubMed ID: 36446884
[TBL] [Abstract][Full Text] [Related]
8. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
9. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
[TBL] [Abstract][Full Text] [Related]
10. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
Hao M; Zang M; Wendlandt E; Xu Y; An G; Gong D; Li F; Qi F; Zhang Y; Yang Y; Zhan F; Qiu L
Int J Cancer; 2015 Apr; 136(8):1835-44. PubMed ID: 25220540
[TBL] [Abstract][Full Text] [Related]
11. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary disease in multiple myeloma: a systematic literature review.
Bladé J; Beksac M; Caers J; Jurczyszyn A; von Lilienfeld-Toal M; Moreau P; Rasche L; Rosiñol L; Usmani SZ; Zamagni E; Richardson P
Blood Cancer J; 2022 Mar; 12(3):45. PubMed ID: 35314675
[TBL] [Abstract][Full Text] [Related]
14. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
[TBL] [Abstract][Full Text] [Related]
15. Extramedullary multiple myeloma.
Weinstock M; Ghobrial IM
Leuk Lymphoma; 2013 Jun; 54(6):1135-41. PubMed ID: 23210572
[TBL] [Abstract][Full Text] [Related]
16. Identification of key genes and miRNA-mRNA regulatory networks associated with bone marrow immune microenvironment regulations in multiple myeloma by integrative bioinformatics analysis.
Tuerxun N; Wang J; Qin YT; Zhao F; Wang H; Qu JH; Uddin MN; Hao JP
Hematology; 2022 Dec; 27(1):506-517. PubMed ID: 35536760
[TBL] [Abstract][Full Text] [Related]
17. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
Liu S; Zhang Y; Huang C; Lin S
J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
[TBL] [Abstract][Full Text] [Related]
18. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
19. Significance of a tumor microenvironment-mediated P65-miR-30a-5p-BCL2L11 amplification loop in multiple myeloma.
Xie L; Wei J; Gao Z; Huang H; Ju S; Wang X
Exp Cell Res; 2022 Jun; 415(1):113113. PubMed ID: 35339472
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
